Rajesh Basnet
19 Yuquan Road
Shijingshan, 100049, China
Shijingshan, 100049, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
An Integrated Cellular Computational Pipeline Decodes Luteolin to Design Possible Allosteric CDK1/CYCLIN B1 Inhibitors That Overcome Breast Cancer Stemness.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 23, 2026
Advances in natural product discovery: strategies, technologies, and insights.
Journal: Natural products and bioprospecting
Published: August 10, 2025
Non-gene-edited neural stem cells reverse neuroinflammation and microbiota dysbiosis in a sprague-dawley rat model of autism spectrum disorder.
Journal: Translational psychiatry
Published: July 27, 2025
The role of laparoscopy in abdominal trauma: a comprehensive diagnostic and therapeutic approach.
Journal: Perioperative medicine (London, England)
Published: July 13, 2025
CDK1 Signaling in Cancer Treatment: Advances in AI-based Strategies and Tools for New Cancer Drug Discovery.
Journal: Combinatorial chemistry & high throughput screening
Published: June 30, 2025
Triple-phase VPA administration in Sprague-Dawley rats: A cost-effective ASD model unveiling the synaptic-mitochondrial-inflammatory axis as a therapeutic target.
Journal: Life sciences
Published: June 11, 2025
Network Pharmacology Reveals Luteolin From Vitex Negundo Novel Targets CDK1/Cyclin B In ER+ Breast Cancer Stem Cells.
Journal: Anti-cancer agents in medicinal chemistry
Published: May 27, 2025
Gut microbiota remodeling exacerbates neuroinflammation and cognitive dysfunction via the microbiota-gut-brain axis in prenatal VPA-exposed C57BL/6 mice offspring.
Journal: Frontiers in immunology
Published: May 23, 2025
Network Pharmacology-based Virtual Screening of Chemical Constituents from Vitexnegundo Linn's Discovered Novel Molecular Targets for Breast Cancer Treatment.
Journal: Current cancer drug targets
Published: April 17, 2024
Enhancing antitumor response by efficiently generating large-scale TCR-T cells targeting a single epitope across multiple cancer antigens.
Journal: Cellular immunology
Published: March 05, 2024
Potential Target of CDK6 Signaling Pathway for Cancer Treatment.
Journal: Current drug targets
Published: March 04, 2024
Last Updated: 09/26/2026